The David King Community Clinical Scientist Award recognizes active community clinical research leaders. Award winners have demonstrated leadership in the development, participation, and evaluation of clinical studies and/or are active in the development of new screening, risk assessment, treatment, or supportive care programs for cancer patients. See past David King Community Clinical Scientist Award winners.
This prestigious award is named after David K. King, MD, FACP, an ACCC past president, who passed away after a brief battle with cancer. Dr. King spent his entire career caring for individuals with cancer and advocating for access to quality care, while also championing the Community Clinical Oncology Program and the value of clinical research in the community setting.
The deadline has been extended for applications and nominations to June 1 for the David King Community Clinical Scientist Award. To apply or nominate, please complete the Award Application/Nomination Form. The Award Selection Committee reviews the applicants and nominees and selects the candidate to recommend to the Board of Trustees for approval. The award recipient will be notified by June 29 and recognized during the 35th ACCC National Oncology Conference in Phoenix, AZ this fall.
The winner receives the following: